 0 Table of Contents |
  1 Home |
  2 Background |
  3 Laboratory Report scenarios |
  4 Managing Laboratory Report statuses |
  5 Design choices |
  6 Challenges |
  7 Implementation notes |
  8 Certified reference material |
  9 Downloads |
  10 Logical Models |
  11 Authors and contributors |
  12 Obligations |
  13 Known Issues |
  14 Dependencies |
  15 Change Log |
  16 Copyright |
  17 Cross-version Analysis |
  18 Mapping to Profiles |
   18.1 EHDS Laboratory Report Mapping |
   18.2 EHDS Laboratory Observation Mapping |
   18.3 EHDS ServiceRequest Mapping |
   18.4 EHDS Specimen Mapping |
   18.5 EHDS MedicationAdministration Mapping |
   18.6 EHDS Device Mapping |
   18.7 EHDS Attachment Mapping |
   18.8 EHDS RelatedPerson Mapping |
  19 Artifacts Summary |
   19.1 Actor Laboratory Report Consumer |
   19.2 Actor Laboratory Report Creator |
   19.3 Actor Laboratory Report Repository |
   19.4 Human Name Obligations |
   19.5 Observation Obligations |
   19.6 Patient Obligations |
   19.7 ServiceRequest Obligations |
   19.8 Specimen Obligations |
   19.9 Bundle: Laboratory Report |
   19.10 Composition: Laboratory Report |
   19.11 DiagnosticReport: Laboratory Report |
   19.12 Observation Results: laboratory |
   19.13 Patient: Animal |
   19.14 ServiceRequest: Laboratory Order |
   19.15 Specimen: Laboratory |
   19.16 Substance: Specimen Additive Substance |
   19.17 Address (EU) |
   19.18 HumanName (Eu) |
   19.19 Quantity (Eu Lab) |
   19.20 Range (Eu Lab) |
   19.21 Ratio (Eu Lab) |
   19.22 Certified Reference Material: CodeableConcept |
   19.23 Certified Reference Material: Identifier |
   19.24 Device Laboratory Test Kit |
   19.25 Document DiagnosticReport Reference |
   19.26 Laboratory Certified Reference Material |
   19.27 Laboratory Code |
   19.28 Laboratory Code: LOINC |
   19.29 Laboratory Code: NPU |
   19.30 Laboratory Order |
   19.31 Laboratory Report Types |
   19.32 Laboratory Specialty |
   19.33 Laboratory Study Types |
   19.34 Laboratory Techniques |
   19.35 Specimen Additive |
   19.36 Specimen Container |
   19.37 Specimen Types |
   19.38 Types of species |
   19.39 Laboratory Code: example |
   19.40 Bundle: converted from CDA |
   19.41 Bundle: Hepatitis Panel |
   19.42 Bundle: Microbiology Culture + Susceptibility |
   19.43 Bundle: MyHealth@EU Proof Of Concept |
   19.44 Bundle: two sections |
   19.45 Composition: example |
   19.46 DiagnosticReport: example |
   19.47 Observation: Aerobic Culture example |
   19.48 Observation: Anaerobic Culture example |
   19.49 Observation: certified reference material |
   19.50 Observation: Gram Staining example |
   19.51 Observation: Gram-positive cocci example |
   19.52 Observation: Gram-positive cocci, observed quantity, example |
   19.53 Observation: Leukocytes Presence example |
   19.54 Observation: ratio example |
   19.55 Observation: Staphylococcus aureus Cephalothin susceptibility example |
   19.56 Observation: Staphylococcus aureus Growth example |
   19.57 Observation: Staphylococcus aureus identified example |
   19.58 Observation: Staphylococcus aureus levoFLOXacin susceptibility example |
   19.59 Observation: Staphylococcus aureus Oxacillin susceptibility example |
   19.60 Observation: Staphylococcus aureus susceptibility panel example |
   19.61 Observation: Staphylococcus aureus Vancomycin susceptibility example |
   19.62 Patient: animal example |
   19.63 Patient: Dutch complete name |
   19.64 Patient: example |
   19.65 Practitioner: example |
   19.66 PractitionerRole: example |
   19.67 ServiceRequest: example |
   19.68 Specimen: animal example |